help shape patient care worldwide

As a leading innovation-driven corporation, Lilly is developing a growing portfolio of pharmaceutical products focused on meeting some of the world's most urgent medical needs.

Lilly’s growing portfolio contains pharmaceutical products that help meet medical needs in the fields of oncology, cardiovascular, diabetes, critical care, neuroscience, men’s health, and musculoskeletal.

Lilly’s commitment to innovation and care does not stop with humans. Elanco, a division of Lilly, is committed to quality care and product innovation for animals through protein production, companion animal health and food safety.